Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
141 results
  1. NLM Digital Collections - Briefing Book, 1989-1990 
    https://resource.nlm.nih.gov/101083016X51
    ... drug is being tested as an alternative to Intravenous Immunoglobulin (IVIG) therapy which takes longer to administer and is more expensive. * Listed in the Physicians Desk Reference ATR(4/90) TERMS USED IN THE DIRECTORY ...
  2. NLM Digital Collections - Analysis of supply, distribution, demand, and access issues associated with immune globulin ... 
    Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2007
    resource.nlm.nih.gov/101615447
    ... been influenced by patient difficulties in obtaining IGIV therapy, including both immune ... for the use of intravenous immunoglobulin in neurological diseases. July. Achiron A, Kishner I, ...
  3. NLM Digital Collections - Hospital literature index (Volume 47) 
    resource.nlm.nih.gov/7807587X34
    ... Emerg Care 1990 Sep;6(3): 183-5 Intravenous immunoglobulin therapy for prevention of infection in high-risk premature ... Coll Cardiol 1990 Dec;16(7):1535-7. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature ...
  4. NLM Digital Collections - Eculizumab and efgartigimod for the treatment of myasthenia gravis : effectiveness and value :... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021
    resource.nlm.nih.gov/9918400686506676
    ... reduce immunosuppressive therapy, the need for ongoing rescue therapy (intravenous immunoglobulin G (IVIg) or plasma exchange [PE]), or the ... state • Documented diagnosis of thrombotic complications to polyclonal intravenous immunoglobulin (IVIG) therapy in the past • PLEX performed within the last ...
  5. NLM Digital Collections - Hospital literature index (Volume 40) 
    resource.nlm.nih.gov/7807587X27
    ... 1983 Nov 4;18(21):1, 11 TRENDS Intravenous immunoglobulin therapy: new aspects and outlook. Imbach P, et al. ... L Imbach P, Barandun S, Baumgartner C, et al: Intravenous immunoglobulin therapy: new aspects and outlook. Blut 1984 Jun;48( ...
  6. NLM Digital Collections - Hospital and health administration index (Volume 52) 
    resource.nlm.nih.gov/9601831X2
    ... 38(10): 1429-46 Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment- ... Bethesda, MD 20892, USA.): Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment- ...
  7. NLM Digital Collections - Hospital and health administration index (Volume 51) 
    resource.nlm.nih.gov/9601831X1
    ... AMBULATORY HOME CARE AGENCIES Home health care costs: intravenous immunoglobulin home infusion therapy. Bielory L, et al. Ann Allergy Asthma Immunol ... 85(7):970-5 Home health care costs: intravenous immunoglobulin home infusion therapy. Bielory L, et al. Ann Allergy Asthma Immunol ...
  8. NLM Digital Collections - AIDS bibliography, 1986-1987 
    Publication: [Bethesda, Md.] : Reference Section, Public Services Division, National Library of Medicine, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1987
    resource.nlm.nih.gov/101036956
    ... Syndrome- ♦COMPLICATIONS/ Adult/ Case Report/ Human/ ♦Immunization, Passive/ Immunoglobulins- ♦ADMINISTRATION & DOSAGE/ Injections, Intravenous/ Male/ Purpura, Thrombocytopenic-^THERAPY Ellwein LB ; Purtilo DT ; Purtilo RB. Decision analysis ...
  9. NLM Digital Collections - Rare diseases. Although limited, available evidence suggests medical and other costs can be ... 
    Publication: Washington, DC : United States Government Accountability Office, October 2021
    resource.nlm.nih.gov/9918383083506676
    ... of Patients with [Primary Immune Deficiency Diseases] Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States. American Health & Drug Benefits, ...
  10. NLM Digital Collections - NIAID Strategic Plan [Draft Excerpts] 
    Publication: Produced: 20 July 1999
    resource.nlm.nih.gov/101584906X13599
    ... many primary immunodeficiency diseases and developed highly effective therapies for this group of disorders — Intravenous immunoglobulin for antibody replacement - Autologous bone marrow transplantation - Granulocyte ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last